abstract |
The present invention provides vectors for the delivery of human leukocyte antigen G to the eye and / or corneal explants, and treatment of corneal transplant rejection and other disorders associated with immune response and / or angiogenesis and / or It relates to methods of using it for prevention. [Selection] Figure 1A |